Number of the records: 1
Dissecting anxiogenic and anxiolytic properties of the CRH/CRHR1- system using genetic mouse models
SYS 0065314 LBL 00000naa--2200000-a-4500 005 20250607140932.4 008 110629c2011----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng 044 $a xo $c SK 242 10
$a Rozoberané anxiogénne a anxiolytické vlastnosti CRH/CRHR1- systému pomocou genetického modelu u myši $y slo 245 10
$a Dissecting anxiogenic and anxiolytic properties of the CRH/CRHR1- system using genetic mouse models / $c D. Refojo ... [et al.] 650 12
$7 sllk_us_auth*d013315 $a stres psychologický $2 mesh 650 12
$7 sllk_us_auth*d018019 $a receptory hormónu uvoľňujúceho kortikotropín $x fyziológia $2 mesh 650 12
$7 sllk_us_auth*d003346 $a hormón uvoľňujúci kortikotropín $2 mesh 650 22
$7 sllk_us_auth*d009452 $a neuroendokrinológia $2 mesh 650 22
$7 sllk_us_auth*d051379 $a myši $9 C $2 mesh 655 -7
$7 sllk_us_auth*d016416 $a abstrakt z kongresu $2 mesh 700 1-
$7 sllk_us_auth*0021442 $a Refojo, D. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021443 $a Schweizer, M. $u Affectis Pharmaceuticals, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021444 $a Kuehne, C. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021445 $a Ehrenberg, S. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021446 $a Thoeringer, C. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021447 $a Vogl, A. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021448 $a Dedic, N. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021449 $a Schumacher, M. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021450 $a Von Wolf, G. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021451 $a Engblom, D. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021452 $a Schuetz, G. $u Cancer Research Center, Heidelberg, Germany $4 aut 700 1-
$7 sllk_us_auth*0021453 $a Deneris, E. $u Case Western Reserve University, School of Medicine, Cleveland, USA $4 aut 700 1-
$7 sllk_us_auth*0021455 $a Nave, K.-A. $u Max Planck Institute of Experimental Medicine, Goettingen, Germany $4 aut 700 1-
$7 sllk_us_auth*0021457 $a Eder, M. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021458 $a Wotjak, C. T. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021459 $a Sillaber, I. $u Affectis Pharmaceuticals, Munich, Germany $4 aut 700 1-
$7 sllk_us_auth*0021460 $a Wurst, W. $u Helmholtz Zentrum München, Institute of Developmental Genetics, Neuherberg, Germany $4 aut 700 1-
$7 sllk_us_auth*p0031049 $a Holsboer, F. $4 aut 700 1-
$7 sllk_us_auth*0021441 $a Deussing, J. M. $u Max Planck Institute of Psychiatry, Munich, Germany $4 aut 711 2-
$7 sllk_us_auth*0021258 $a Symposium on catecholamines and other neurotransmitters in stress $n (10. : $d 2011 : $c Smolenice, Slovensko) 773 0-
$7 nnas $w sllk_us_cat*0064689 $t Endocrine regulations $x 1210-0668 $d Bratislava : AEPress, 2011 $g Vol. 45, no. 2 (2011), s. [144]
Number of the records: 1